10/31/2014 - 1:15pm

Treasury Department aide Alastair “Al” Fitzpayne has been tapped as the Department of Health and Human Services’ next chief of staff, the Wall Street Journal reported.

10/31/2014 - 12:46pm

The response to the current global Ebola scare from both the pharmaceutical and pharmacy industries has been nothing short of remarkable. Precautionary preparations have been made to address the Ebola concerns in the United States; several pharmaceutical manufacturers have been working around the clock toward an Ebola vaccine and treatment; and there has been an outpooring of goods that have been directed to help with the outbreak in West Africa. 

Ebola is not a problem in the United States, at least not yet (nor hopefully will it ever be), but the pharmaceutical community is stepping up to help around the world. And in the U.S., there is much being done to help the pharmacy world prepare.

 

10/31/2014 - 11:34am

Allstar Products Group is celebrating the November launch of its Hot Jewels Metallic Temporary Tattoos, the latest addition to the Hot Looks family, with a Facebook giveaway.

10/31/2014 - 11:08am

Novo Nordisk announced the launch of NovoFine Plus in the United States. NovoFine Plus is a universal needle that works with all currently available insulin, as well as some GLP-1 receptor agonist pens, the company said. 

 

10/31/2014 - 10:57am
ZAO

ZAO Organic Makeup is announcing its North American launch.

 

10/31/2014 - 10:37am

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.

10/31/2014 - 10:35am

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

10/31/2014 - 10:22am

The signs for the retail clinic industry remain positive and conservative but steady growth in the number of clinics is expected to continue as drug stores play an essential role in the segment, according to new research from healthcare market researcher Kalorama Information.

10/31/2014 - 9:41am

Rite Aid's 5.5% lift in same-store sales for the four weeks ended Oct. 25 exceeded analyst consensus of 4%, Credit Suisse research analyst Ed Kelly reported in a note Thursday.